Scarica l'app Stockscreener
26.66
2.18%
0.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
Will Assembly Biosciences Inc. stock benefit from infrastructure spendingJuly 2025 Intraday Action & Expert Approved Momentum Ideas - mfd.ru
What is Assembly Biosciences Inc. s 5 year growth outlookJuly 2025 Institutional & Capital Efficient Trading Techniques - mfd.ru
Bearish Setup: Can Assembly Biosciences Inc stock double in the next yearJuly 2025 Gainers & Real-Time Buy Signal Notifications - baoquankhu1.vn
Layoff Watch: Is Assembly Biosciences Inc benefiting from innovation trendsQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
(ASMB) Volatility Zones as Tactical Triggers - Stock Traders Daily
Assembly Biosciences completes key phase 1a study on ABI-6250 - MSN
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Resistance Check: Whats the beta of Assembly Biosciences Inc stockJuly 2025 Chart Watch & Safe Entry Point Alerts - baoquankhu1.vn
Earnings Report: Can Brinker International Inc continue delivering strong returnsWeekly Trade Report & Smart Investment Allocation Insights - baoquankhu1.vn
What are Assembly Biosciences Inc.’s earnings expectations2025 Retail Activity & Daily Market Momentum Tracking - Mfd.ru
Short Covering: What is the target price for Assembly Biosciences Inc stock2025 Short Interest & Community Verified Swing Trade Signals - baoquankhu1.vn
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Price-Driven Insight from (ASMB) for Rule-Based Strategy - Stock Traders Daily
Sentiment Watch: Can Assembly Biosciences Inc disrupt its industryMarket Activity Report & Growth Focused Investment Plans - baoquankhu1.vn
Published on: 2026-01-26 23:16:19 - baoquankhu1.vn
Some Confidence Is Lacking In Assembly Biosciences, Inc. (NASDAQ:ASMB) As Shares Slide 27% - simplywall.st
Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials - MSN
Financial Survey: Assembly Biosciences (NASDAQ:ASMB) and Sol-Gel Technologies (NASDAQ:SLGL) - Defense World
Aug Volume: Should I trade or invest in Assembly Biosciences IncJuly 2025 Momentum & Reliable Entry Point Alerts - baoquankhu1.vn
Technical Analysis: What is Assembly Biosciences Incs 5 year growth outlookNew Guidance & Target Return Focused Stock Picks - baoquankhu1.vn
Returns Recap: Can Assembly Biosciences Inc disrupt its industryVolume Spike & Growth Oriented Trade Recommendations - baoquankhu1.vn
(ASMB) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Risks Report: What is the target price for Assembly Biosciences Inc stockTrade Performance Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Assembly Biosciences Shares Find Technical Footing - AD HOC NEWS
Momentum Shift: How liquid is Assembly Biosciences Inc stockWeekly Profit Analysis & Community Trade Idea Sharing Platform - baoquankhu1.vn
Fed Meeting: Is Assembly Biosciences Inc benefiting from innovation trendsTrade Analysis Report & Consistent Profit Trading Strategies - baoquankhu1.vn
Exit Recap: Is Assembly Biosciences Inc impacted by rising ratesLayoff News & Smart Swing Trading Alerts - baoquankhu1.vn
Assembly Biosciences (ASMB) Sees Raised Price Target From Mizuho - GuruFocus
Gains Recap: What is the target price for Assembly Biosciences Inc stockEarnings Growth Report & High Accuracy Buy Signal Tips - baoquankhu1.vn
Portfolio Recap: How Assembly Biosciences Inc stock reacts to inflationary pressures2025 Volatility Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ
Bull Run: Why Assembly Biosciences Inc V7B stock is a must watch tickerJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - Bộ Nội Vụ
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in ‘significantly de-risks’ genital herpes programs - MSN
Assembly Biosciences (ASMB) price target increased by 24.84% to 48.70 - MSN
Assembly Biosciences (NASDAQ:ASMB) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Assembly Biosciences (NASDAQ:ASMB) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
How strong is Assembly Biosciences Inc. stock revenue growthWeekly Profit Recap & Precise Trade Entry Recommendations - ulpravda.ru
Aug Sectors: How Assembly Biosciences Inc. stock reacts to global recession fearsPrice Action & Advanced Technical Signal Analysis - Улправда
How Assembly Biosciences Inc. stock reacts to global recession fearsPrice Action & Advanced Technical Signal Analysis - Улправда
Why Assembly Biosciences Inc. (V7B) stock is a must watch ticker2025 Stock Rankings & Consistent Growth Equity Picks - Улправда
Is Assembly Biosciences Inc. stock attractive after correction2025 AllTime Highs & Short-Term Trading Opportunity Alerts - Улправда
What risks investors should watch in Assembly Biosciences Inc. stockMarket Risk Analysis & Weekly High Conviction Ideas - ulpravda.ru
Assembly Biosciences Stock Faces Crucial Technical Test - AD HOC NEWS
Why Assembly Biosciences Inc. stock remains a top recommendation2026 world cup usa national team third place match star players low block defense winner prediction guide - ulpravda.ru
(ASMB) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Stock Price Up 4% – Time to Buy? - Defense World
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Trading 4% HigherHere's What Happened - MarketBeat
After 25 Years, Recurrent Genital Herpes Treatment Gains Corporate Partner - Vax-Before-Travel
Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for... - Medical Dialogues
Ellsworth Advisors LLC Acquires New Holdings in Assembly Biosciences, Inc. $ASMB - Defense World
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in 'significantly de-risks' genital herpes programs - MSN
Technical Reactions to ASMB Trends in Macro Strategies - Stock Traders Daily
With 32% ownership, Assembly Biosciences, Inc. (NASDAQ:ASMB) has piqued the interest of institutional investors - Yahoo Finance
Assembly Biosciences price target raised to $40 from $29 at Mizuho - MSN
Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 6%What's Next? - MarketBeat
GILD Exercises Option to License Assembly Bio's Herpes Programs - WV News
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes - BioSpace
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Sahm
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):